On July 2, 2024, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) regarding the Medicare Drug Price Negotiation Program Guidance. Aimed Alliance urged CMS to ensure their listening process is genuine, inclusive, and effective. Key recommendations included providing clear guidance for listening sessions, promoting diversity through varied session times and formats, and allowing patient advocates and advocacy organizations to speak on behalf of their communities. These enhancements aim to improve the quality of feedback CMS receives by ensuring diverse perspectives are represented, alleviating the burden of providing insights from falling solely on patients, and fostering more productive and focused discussions tailored to CMS’s needs. Read the comment here.
Last Updated on July 5, 2024 by Aimed Alliance
